5 results on '"Ye, Xin"'
Search Results
2. Safety and efficacy of microwave ablation for lung cancer adjacent to the interlobar fissure.
- Author
-
Wang, Nan, Xu, Jingwen, Wang, Gang, Xue, Guoliang, Li, Zhichao, Cao, Pikun, Hu, Yanting, Cai, Hongchao, Wei, Zhigang, and Ye, Xin
- Subjects
PNEUMONIA ,PLEURAL effusions ,LUNG tumors ,MICROWAVES ,RETROSPECTIVE studies ,SURGICAL complications ,TREATMENT effectiveness ,SURVIVAL analysis (Biometry) ,PROGRESSION-free survival ,ABLATION techniques ,PATIENT safety ,PNEUMOTHORAX - Abstract
Background: This retrospective study aimed to assess the safety and efficacy of microwave ablation for lung tumors adjacent to the interlobar fissures. Methods: From May 2020 to April 2021, 59 patients with 66 lung tumors (mean diameter, 16.9 ± 7.7 mm; range, 6–30 mm) adjacent to the interlobar fissures who underwent microwave ablation at our institution were identified and included in this study. Based on the relationship between the tumor and the interlobar fissure, tumors can be categorized into close to the fissure, causing the fissure, and involving the fissure. The complete ablation rate, local progression‐free survival, complications, and associated factors were analyzed. Results: All 66 histologically proven tumors were treated using computed tomography‐guided microwave ablation. The complete ablation rate was 95.5%. Local progression‐free survival at 3, 6, 9, and 12 months were 89.4%, 83.3%, 74.2%, and 63.6%, respectively. The complications included pneumothorax (34.8%), pleural effusion (24.2%), cavity (18.2%), and pulmonary infection (7.6%). There were statistical differences in the incidence of pneumothorax, cavity, and delayed complications between the groups with and without antenna punctures through the fissure. Conclusions: Microwave ablation is a safe and effective treatment for lung tumor adjacent to the interlobar fissure. Antenna puncturing though the interlobar fissure may be a potential risk factor for pneumothorax, cavity, and delayed complications. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
3. Multicentre study of microwave ablation for pulmonary oligorecurrence after radical resection of non-small-cell lung cancer.
- Author
-
Ni, Yang, Peng, Jinchao, Yang, Xia, Wei, Zhigang, Zhai, Bo, Chi, Jiachang, Li, Xiaoguang, and Ye, Xin
- Subjects
LUNG cancer ,RESEARCH ,MULTIVARIATE analysis ,RESEARCH methodology ,LUNG tumors ,RETROSPECTIVE studies ,PROGNOSIS ,MICROWAVES ,MEDICAL cooperation ,EVALUATION research ,TREATMENT effectiveness ,COMPARATIVE studies ,ABLATION techniques - Abstract
Background: Microwave ablation (MWA) is an effective minimally invasive technique for lung tumours. We aim to evaluate its role for pulmonary oligorecurrence after radical surgery of non-small-cell lung cancer (NSCLC).Methods: From June 2012 to Jan 2020, a total of 103 patients with pulmonary oligorecurrence after previous radical surgical resection of NSCLC were retrospectively analysed. The primary endpoint was postoperative progression-free survival (PFS). Secondary endpoints were postoperative overall survival (OS), patterns of failure, complications and predictive factors associated with prognosis.Results: Of the 103 patients identified, 135 pulmonary oligorecurrences developed at a median interval of 34.8 months. In total, 143 sessions of MWA were performed to ablate all the nodules. The median PFS and OS were 15.1 months and 40.6 months, respectively. After MWA, 15 (14.6%) patients had local recurrence as the first event, while intrathoracic oligorecurrence and distant metastases were observed in 45 (43.7%) and 20 (19.4%) patients, respectively. In the multivariate analysis, local recurrence and intrathoracic oligorecurrence were not significant predictors for OS (P = 0.23 and 0.26, respectively). However, distant metastasis was predictive of OS (HR = 5.37, 95% CI, 1.04-27.84, P = 0.04).Conclusion: MWA should be considered to be an effective and safe treatment option for selected patients with pulmonary oligorecurrence after NSCLC radical surgical resection. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
4. Safety and clinical outcomes of computed tomography‐guided percutaneous microwave ablation in patients aged 80 years and older with early‐stage non‐small cell lung cancer: A multicenter retrospective study.
- Author
-
Han, Xiaoying, Yang, Xia, Huang, Guanghui, Li, Chunhai, Zhang, Licheng, Qiao, Yuanxun, Wang, Chuntang, Dong, Yuting, Chen, Xiangming, Feng, Qingliang, Wang, Chuandai, Rong, Zhenhua, Ding, Kun, Wei, Zhigang, Ni, Yang, Wang, Jiao, Li, Wenhong, Meng, Min, and Ye, Xin
- Subjects
LUNG cancer prognosis ,SURGICAL complication risk factors ,COMPUTED tomography ,HEALTH facilities ,LUNG cancer ,MEDICAL cooperation ,PLEURA cancer ,PLEURAL effusions ,PNEUMOTHORAX ,RESEARCH ,TUMOR classification ,TREATMENT effectiveness ,RETROSPECTIVE studies ,DISEASE progression ,ABLATION techniques ,DISEASE risk factors ,OLD age - Abstract
Background: Previous studies have documented the therapeutic value of computed tomography (CT)‐guided percutaneous microwave ablation (MWA) for early‐stage non‐small cell lung cancer (NSCLC). However, few studies have focused on patients aged 80 years and older. This retrospective study aimed to evaluate the safety and clinical outcomes of CT‐guided percutaneous MWA in patients aged 80 years and older with early‐stage peripheral NSCLC. Methods: A retrospective analysis of 63 patients aged 80 years and older with cT1a‐2bN0M0 peripheral NSCLC who underwent CT‐guided percutaneous MWA was performed between January 2008 and January 2018 at 11 hospitals in Shandong Province, China. Results: The median follow‐up time was 21.0 months. The overall median survival time was 50 months. The cancer‐specific median survival time was not reached in five years. The one‐, two‐, three‐, four‐, and five‐year overall survival rates were 97.1%, 92.6%, 63.4%, 54.4%, and 32.6%, respectively. The one‐, two‐, and three‐year cancer‐specific survival (CSS) rates were 97.9%, 97.9%, and 69.4%, respectively. The four‐ and five‐year CSS rates were not achieved. A total of 14 patients (22.2%) had local progression. The one‐, two‐, three‐, four‐, and five‐year local control rates were 88.8%, 78.8%, 70.3%, 63.9%, and 63.9%, respectively. The mortality rate was 0% within 30 days after the procedure. Major complications included pneumothorax requiring drainage (21.1%), pulmonary infection (4.2%), and pleural effusions requiring drainage (2.8%). Conclusions: CT‐guided percutaneous MWA is a safe and effective modality for treating patients aged 80 years and older with early‐stage peripheral NSCLC. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
5. Microwave ablation for lung cancer patients with a single lung: Clinical evaluation of 11 cases.
- Author
-
Yang, Xia, Ye, Xin, Zhang, Licheng, Geng, Dianzhong, Du, Zhenli, Yu, Guohua, Ren, Haipeng, Wang, Jiao, Huang, Guanghui, Wei, Zhigang, Ni, Yang, Li, Wenhong, and Han, Xiaoying
- Subjects
- *
LUNG cancer prognosis , *CANCER relapse , *COMPUTED tomography , *HEMOPTYSIS , *HEMORRHAGE , *INFECTION , *LUNG cancer , *MICROWAVES , *PLEURAL effusions , *PNEUMONECTOMY , *PNEUMOTHORAX , *POSTOPERATIVE period , *SURGICAL complications , *TREATMENT effectiveness , *RETROSPECTIVE studies , *ABLATION techniques - Abstract
Background: The study was conducted to retrospectively evaluate the safety and effectiveness of computed tomography (CT)‐guided percutaneous microwave ablation (MWA) for peripheral non‐small cell lung cancer (NSCLC) in 11 patients with a single lung after pneumonectomy. Methods: From May 2011 to March 2015, 11 single‐lung patients (8 men and 3 women; mean age 60.3 years, range 46–71) with peripheral NSCLC underwent 12 sessions of MWA. Eleven tumors measuring 13–52 mm (mean 30.2 mm) were treated. Follow‐up was performed via CT scan at 1, 3, 6, 12, 18, and 24 months after the procedure and annually thereafter. Clinical outcomes were evaluated and complications after MWA were summarized. Results: At a median follow‐up period of 20 months (range 6–38), four patients showed evidence of local recurrence at a rate of 36.4% (4/11). Median overall survival was 20 months. The overall survival rates at one, two, and three years after MWA were 88.7%, 63.6%, and 42.3%, respectively. Complications after MWA included pneumothorax (33.3%), hemoptysis (33.3%), intrapulmonary bleeding (25%), pleural effusion (16.7%), and pulmonary infection (8.3%). None of the patients died during the procedure or in the 30 days after MWA. Conclusion: CT‐guided percutaneous MWA is safe and effective for the treatment of peripheral NSCLC in patients with a single lung after prior pneumonectomy. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.